Moderna is proactively working to ensure it recruits a diverse patient base that will hit clinical outcomes for its Phase III vaccine trial • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
